CUMBERLAND PHARMACEUTICALS INC 4
4 · CUMBERLAND PHARMACEUTICALS INC · Filed May 1, 2015
Insider Transaction Report
Form 4
Griggs Jonathan
Director
Transactions
- Exercise/Conversion
Common stock
2015-04-28$6.69/sh+700$4,683→ 6,645 total - Exercise/Conversion
Options
2015-04-28−700→ 0 totalExercise: $6.69From: 2010-06-01Exp: 2015-06-01→ Common stock (700 underlying)
Footnotes (1)
- [F1]Exercise of stock options awarded under the issuers Directors' Incentive Plan. These stock options had an expiration date of June 1, 2015.